Yeon-ho Chung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.
Journal: Neuro-oncology
Published: December 28, 2024
Inhibition of SOD1 trimerization is a novel drug target for ALS disease.
Journal: Translational neurodegeneration
Published: November 11, 2024
NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues.
Journal: International journal of molecular sciences
Published: May 04, 2024
Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.
Journal: Cells
Published: August 08, 2023
Dysfunction in parkin aggravates inflammatory bone erosion by reinforcing osteoclast activity.
Journal: Cell & bioscience
Published: November 23, 2022
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.
Journal: Scientific reports
Published: August 09, 2016
Monosodium urate crystal-induced pro-interleukin-1β production is post-transcriptionally regulated via the p38 signaling pathway in human monocytes.
Journal: Scientific reports
Published: April 14, 2016
Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis.
Journal: The Journal of biological chemistry
Published: July 22, 2015
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.
Journal: Arthritis research & therapy
Published: June 18, 2015
Interleukin-1β promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca²⁺-dependent activation of ERK.
Journal: The international journal of biochemistry & cell biology
Published: March 07, 2014
Last Updated: 09/26/2026